✉news HealthNutrition first seen 3 d ago, last 3 d ago, peak #32
Napo Pharmaceuticals panel on crofelemer at Dubai pediatric gastroenterology conference
Original: CSO of Napo Pharmaceuticals, a Jaguar Health Family Company, and Clinical Investigators Evaluating Crofelemer Conduct Panel Discussion at Pediatric Gastroenterology Conference in Dubai (UAE)
The chief scientific officer of Napo Pharmaceuticals, a Jaguar Health company, joined clinical investigators studying the drug crofelemer for a panel discussion at a pediatric gastroenterology conference in Dubai, United Arab Emirates. The discussion focused on the company's ongoing evaluation of crofelemer and drew attention to the drug's potential role in pediatric gastrointestinal care.
Why now: The company publicly highlighted its pediatric-focused research and presence at a major regional medical conference.
Napo PharmaceuticalsJaguar HealthcrofelemerDubai
Evidence
- CSO of Napo Pharmaceuticals, a Jaguar Health Family Company, and Clinical Investigators Evaluating Crofelemer Conduct Panel Discussion at Pediatric Gastroenterology Conference in Dubai (UAE) · azcentral.com and The Arizona Republic
API: https://socialmediatrends-api.osmike.com/v1/trends/4638406